Bioorganic and Medicinal Chemistry p. 6267 - 6272 (2017)
Update date:2022-08-30
Topics:
Christoff, Rebecca M.
Murray, Gerald L.
Kostoulias, Xenia P.
Peleg, Anton Y.
Abbott, Belinda M.
With multidrug resistant bacteria on the rise, novel antibiotics are becoming highly sought after. In 2008, eleven compounds were identified by high throughput screening as inhibitors of BasE, a key enzyme of the non-ribosomal peptide synthetase pathway found in Acinetobacter baumannii. Herein, we describe the preparation of four structurally similar heterocyclic lead compounds from that study, including one 1,2,5-oxadiazole. A further library of 30 analogues containing the oxadiazole moiety was then generated. All compounds were screened against Acinetobacter baumannii and their minimum inhibitory concentration data is reported, with (E)-3-(2-hydroxyphenyl)-N-(4-methyl-1,2,5-oxadiazol-3-yl)acrylamide 32 found to have an MIC of 0.5 mM. This work provides the foundation for further investigation of 1,2,5-oxadizoles as novel inhibitors of A. baumannii.
View MoreShanghai Hongbang Medical Technology CO.,. Ltd
Contact:13671516988 /18917636693
Address:Room1, No67 Building, Yongde Road369, Wujing Town, Minhang Districy, Shanghai CIty, China.
Contact:+65 9658 0999
Address:26 Sin Ming Lane, Midview City, #05-118, Singapore 573971
Hangzhou innopharma technology Co,.Ltd.
Contact:+86-13388601988
Address:Room845,lixin building, moganshan road, hangzhou, china
Xi'an caijing Opto-Electrical Science & Technology Co., LTD
Contact:+86-29-88294447
Address:NO.168 Zhangba Rd. East, Xi'an, P.R.China
Contact:+86-27-67841589
Address:Add: 999 Gaoxin Road, Donghu New Technology Development Zone, Wuhan City, Hubei, China
Doi:10.1039/jr9340000218
(1934)Doi:10.1016/S0022-0728(79)80053-4
(1979)Doi:10.1007/BF00457999
(1956)Doi:10.1055/s-0032-1317018
(2012)Doi:10.1016/j.poly.2019.114128
(2019)Doi:10.1016/j.apcata.2016.03.012
(2016)